Al Ketbi: We are working on the optimum deployment of technology in order to empower patients, enhance patient convenience and care.

Dubai, United Arab Emirates: The Dubai Health Authority recently announced its plans to enhance the use of smart health technologies on the occasion of the UAE Innovation Month 2021.

DHA has collaborated with Enpy, a Dubai firm; to explore the use of AI-powered device for remote-patient monitoring. Enpy is a start-up UAE company, based in Dubai, specializing in Medical Artificial Intelligence. It has designed the non-invasive innovative medical device.

DHA is also expanding and adding newer specializations to its Doctor for Every Citizen telemedicine service.

During his inspectional visit of the DHA’s Innovation Centre, His Excellency Awadh Al Ketbi, Director General of the Dubai Health Authority emphasized the importance of fostering and promoting a culture of innovation, particularly in the health sector. He added that the DHA will continue to focus on research, innovation and implementation of smart technologies across all aspects of healthcare delivery and management. At the same time, the authority will continue its focus on medical education and specializations in the health sector. 

DHA plans to implement such technologies across its primary healthcare centres to foster its remote patient monitoring initiatives to empower patients, ensure they stay on-track with their health and to aid in early detection.  It will also help healthcare professionals by providing them with vital patient data to ensure regular follow-up and better patient compliance. 

Dr. Manal Taryam, CEO of Primary Healthcare Sector at the DHA said, “We are keen to use the latest health technologies with an aim to better both healthcare management and patient-centered care. Over the last few years, we have focused on home patient monitoring especially for elderly patients. We have also swiftly foraged into telemedicine. The use of technology for remote-patient monitoring is of particular importance in the current healthcare landscape of the world and we are keen to continue collaborating with firms locally and globally to implement healthcare technologies after an evidence-based analysis.”

Epsy’s innovative all-in-one non-invasive medical device is paired with a smartphone/tablet application, it is powered by Artificial Intelligence and measures vital signs.  It is an all-in-one advanced AI-powered healthcare companion at home, combining integrated medical sensors, embedded electronics, and a unique user-interface to guide users regularly in making the best decisions for their health.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.